SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisitions/Trading Update

13 Dec 2007 07:01

CVS Group plc13 December 2007 For Immediate Release 13 December 2007 CVS Group plc ("CVS" or "the Group") Acquisitions and Pre-close Trading Update Acquisitions CVS, one of the UK's leading providers of veterinary services, is pleased toannounce three single site practice acquisitions located in Kidsgrove inStaffordshire, Fleet in Hampshire and Doncaster. The practices achieved aggregate EBITDA of £276,000 on turnover of £1.986m fortheir respective latest financial reporting periods. The consideration, which isnot being disclosed for reasons of commercial sensitivity, is being satisfiedwholly in cash. The acquired practices employ a total of 10 vets bringing the Group total toalmost 300. Commenting on the acquisitions, CVS Chief Executive Simon Innes said "Each ofthese three practices enjoys a strong reputation for clinical care and we lookforward to developing an excellent long term relationship with their respectiveteams". Pre-close Trading Update With five months of the current financial year now behind us the Board isdelighted to report continued strong progress on all fronts. We started the financial year with 43 small animal practices operating from 120surgeries and with one equine specialist practice and three veterinarydiagnostic laboratories. In the period up to flotation in early October weacquired a further two small animal practices operating from seven surgerieswhich, together with the significant number of acquisitions made in the secondhalf of last financial year, gave us a substantially higher EBITDA run-rate thanthe actual historic EBITDA of £5.1m achieved for the year ended 30 June 2007. Since flotation we have acquired a further four small animal practices,including the three announced today, operating from six surgeries and employing24 vets. Our pipeline of potential acquisitions remains strong, assisted by thedemographics which have now been prevalent in the sector for a few years. We will remain focused on acquiring well established practices achievingexcellence in terms of clinical care and where each practice employs at leastthree vets. The central services provided by the Group remain very attractive tovets, enabling individual surgeries to focus on clinical care. Our organic growth continues to be firm and we are confident of achievinganother year of significant progress in executing our strategy. Contacts:CVS Group plc 01379 644 288Simon Innes, Chief ExecutivePaul Coxon, Finance Director Buchanan CommunicationsRichard Oldworth 0207 466 5000Suzanne Brocks 07776 234 600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments
29th Nov 20197:00 amRNSResult of AGM
28th Nov 20197:00 amRNSAnnual General Meeting Statement
21st Nov 201910:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.